Since each type of cancer will use its own specific antibody, they would need to do a trial for each specific indication. We should at least have some good data on safety and adverse effects at that time, so trials would be geared at demonstrating efficacy and determining the specificity/sensitivity of the antibodies.
Human Trial, page-3
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| IBX (ASX) Chart |
Day chart unavailable